Primary Category:
Radiation Oncology, Treatment Protocols
Disease Category:
Brain
Status:
Temporarily Closed
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
NCT#04396860
BN007 is temporarily closed to accrual effective April 27, 2022 at 5pm ET.
